Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
CRL
CRL
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest CRL ETF News Today | Earnings, Events & Price Alerts
CRL News
Top and Bottom Performing S&P 500 Stocks in February
4d ago
Barron's
Charles River Laboratories Plans Business Divestitures
Feb 25 2026
Benzinga
Mizuho Lowers Target Price for Charles River Laboratories International Inc. to $175 from $215
Feb 20 2026
moomoo
Charles River Laboratories Q4 2025 Earnings Highlights
Feb 18 2026
seekingalpha
US Stock Markets Rise on Strong Economic Data
Feb 18 2026
NASDAQ.COM
Stock Movements of Various Companies Analyzed
Feb 18 2026
CNBC
US Stock Markets Rise on Positive Economic Data
Feb 18 2026
NASDAQ.COM
Charles River Executive Anticipates High-Teens Drop in Q1 Adjusted EPS Compared to Last Year
Feb 18 2026
moomoo
CHARLES RIVER EXECUTIVE STATES THAT OPERATIONAL MARGIN EXPANSION WILL DRIVE MOST OF THE EARNINGS PER SHARE GROWTH IN 2026
Feb 18 2026
moomoo
CHARLES RIVER EXECUTIVE STATES IT WILL TAKE 1-2 QUARTERS TO REALIZE BENEFITS FROM STRONG 4Q25 BOOKINGS
Feb 18 2026
moomoo
CHARLES RIVER LABORATORIES EXECUTIVE AFFIRMS COMMITMENT TO ASSESS FURTHER M&A OPPORTUNITIES, FOCUSING ON BIOANALYSIS AND GEOGRAPHICAL GROWTH - CONFERENCE CALL
Feb 18 2026
moomoo
CHARLES RIVER EXECUTIVE EXPRESSES SURPRISE AT VIOLENT SHARE PRICE REACTION TO AI DISCUSSIONS ACROSS VARIOUS INDUSTRIES
Feb 18 2026
moomoo
CHARLES RIVER EXECUTIVE PREDICTS SIGNIFICANT IMPROVEMENT IN OPERATING MARGIN POST-Q1
Feb 18 2026
moomoo
Charles River Laboratories Reports 2025 Financial Results and 2026 Guidance
Feb 18 2026
Newsfilter
Charles River Appoints New Executives
Feb 18 2026
Newsfilter
Charles River Laboratories Releases 2026 Financial Guidance
Feb 18 2026
seekingalpha
Show More News
